Value proposition

Combining human and machine intelligence to accelerate the discovery of uniquely powerful antibodies.

LabGenius is the first biopharmaceutical company developing next generation protein therapeutics using a machine learning-driven evolution engine (EVATM).

Our protein engineering platform integrates several bleeding edge technologies
from the fields of machine learning, synthetic biology and robotics.

Synthetic Biology, Protein Engineering, Artificial Intelligence, Machine Learning, High Throughput Screening, Medical, Health, DNA Libraries, drug discovery, and protein therapeutics